-+ 0.00%
-+ 0.00%
-+ 0.00%

Ocugen to present modifier gene therapy platform at Oppenheimer biotech summit

PUBT·07/31/2026 11:03:51
Listen to the news
Ocugen to present modifier gene therapy platform at Oppenheimer biotech summit
  • Ocugen will present its modifier gene therapy platform at the Oppenheimer Biotech in the Berkshires Summit on Aug. 4, 2026, in Lenox, Massachusetts.
  • The company will also take part in the Canaccord Annual Growth Conference on Aug. 11, 2026, in Boston.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocugen Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607310702PRIMZONEFULLFEED9800977) on July 31, 2026, and is solely responsible for the information contained therein.